Étude 1 :
Current Status of Pharmacological Potentials of Phycocyanin. by Apurva Gupta et al. World Journal of Pharmaceutical Sciences ISSN (Print): 2321-3310; ISSN (Online): 2321-3086. 2016. India.
Étude 2 : Torres-Durán, P.V., Miranda-Zamora, R., Paredes-Carbajal, M.C., Mascher, D., Díaz-Zagoya, J.C. and Juárez-Oropeza, M.A. (1998),
Spirulina maxima prevents induction of fatty liver by carbon tetrachloride in the rat. IUBMB Life, 44: 787-793.
Étude 3 : Reddy, C M et al. “
Selective inhibition of cyclooxygenase-2 by C-phycocyanin, a biliprotein from Spirulina platensis.” Biochemical and biophysical research communications vol. 277,3 (2000): 599-603. doi:10.1006/bbrc.2000.3725